```

[Federal Register Volume 89, Number 246 (Monday, December 23, 2024)]
[Notices]
[Page 104550]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30604]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration

Advisory Council on Blood Stem Cell Transplantation

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's Advisory Council on Blood Stem 
Cell Transplantation (ACBSCT or Council) has scheduled a public 
meeting. Information about ACBSCT and the agenda for the meeting can be 
found on the ACBSCT website at https://bloodstemcell.hrsa.gov/about/advisory-council.

DATES: Thursday, January 23, 2025, 3:00 p.m.-5:00 p.m. Eastern Standard 
Time.

ADDRESSES: This meeting will be held virtually by webinar. A link to 
register and join the meeting will be posted at least 10 days prior to 
the meeting at https://bloodstemcell.hrsa.gov/about/advisory-council.

FOR FURTHER INFORMATION CONTACT: Shelley Tims Grant, Designated Federal 
Official, Division of Transplantation, Health Systems Bureau, HRSA, 
5600 Fishers Lane, 8W-67, Rockville, Maryland 20857; 301-443-8036; or 
[email protected].

SUPPLEMENTARY INFORMATION: ACBST provides advice and recommendations to 
the Secretary of HHS (Secretary) on policy, program development, and 
other matters of significance concerning the activities under the 
authority of 42 U.S.C. 274k (Section 379 of the Public Health Service 
Act), Public Law 109-129, as amended. The Council may transmit its 
recommendations through the Administrator of HRSA on matters related to 
the activities of the C.W. Bill Young Cell Transplantation Program and 
National Cord Blood Inventory.
    The agenda for the January 23, 2025, meeting is being finalized and 
may include the following topics: graft versus host disease and late 
effects, strategies for selecting cord blood units for transplantation, 
HHS' approach for reviewing the state of the science and 
recommendations on the appropriateness of the inclusion of adult stem 
cells and birthing tissues as new types of therapies in the C.W. Bill 
Young Cell Transplantation Program, and other areas to increase blood 
stem cell donation and transplantation. Agenda items are subject to 
change as priorities dictate. Refer to ACBSCT's website for any updated 
information concerning the meeting. Members of the public will have the 
opportunity to provide comments. Public participants may submit written 
statements in advance of the scheduled meetings; oral comments will be 
honored in the order they are requested and may be limited as time 
allows. Requests to submit a written statement or make oral comments to 
ACBSCT should be sent to Shelley Tims Grant, using the contact 
information above at least 3 business days prior to the meeting. 
Individuals who plan to attend and need special assistance or other 
reasonable accommodations should notify ACBSCT at the address and phone 
number listed above at least 10 business days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024-30604 Filed 12-20-24; 8:45 am]
BILLING CODE 4165-15-P
```